Stryker Corporation (SYK)
| Market Cap | 146.17B |
| Revenue (ttm) | 21.97B |
| Net Income (ttm) | 3.59B |
| Shares Out | 381.22M |
| EPS (ttm) | 9.33 |
| PE Ratio | 41.11 |
| Forward PE | 29.17 |
| Dividend | $3.36 (0.88%) |
| Ex-Dividend Date | Dec 31, 2024 |
| Volume | 1,456,997 |
| Open | 385.00 |
| Previous Close | 381.79 |
| Day's Range | 379.00 - 385.82 |
| 52-Week Range | 307.23 - 398.20 |
| Beta | 0.96 |
| Analysts | Buy |
| Price Target | 408.21 (+6.47%) |
| Earnings Date | Jan 28, 2025 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ... [Read more]
Financial Performance
In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $408.21, which is an increase of 6.47% from the latest price.
News
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purc...
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medical, I...
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable January 31, 2025 to sharehold...
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Last year, Morgan Stanley upgraded its outlook for the U.S. MedTech sector to “Attractive,” believing the concerns around GLP-1s were already reflected in stock prices and that fundamentals were stron...
Stryker Bringing in Big Money
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination
FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to...
Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management ...
Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript
Stryker Corporation. (NYSE:SYK) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance ...
Stryker: A High Quality MedTech Name Investors Should Own
Stryker Corporation is a global leader in medical devices, with strong growth prospects driven by an aging population and technological advancements. SYK has a robust track record of double-digit earn...
Stryker: More Earnings Growth And Higher Prices Ahead
Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial resul...
Stryker's Acquisition Spree: Double-Digit Growth on the Horizon
Stryker SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boost its ...
Stryker to announce its third quarter 2024 financial results
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024. A press release will be is...
Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management soluti...
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
PORTAGE, Mich., USA, Sept.
Stryker completes acquisition of care.ai
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in del...
Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
EMERYVILLE, Calif. , Sept. 12, 2024 /PRNewswire/ -- Eko Health , a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, today announced the appointment of B...
Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker announced the addition of the Osteotomy Truss System™ and Ankle Truss System™ to its Foot & Ankle portfolio, which will be featured at AOFAS.
Stryker Corporation (SYK) Wells Fargo 2024 Healthcare Conference (Transcript)
Stryker Corporation (NYSE:SYK) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 3:00 PM ET Company Participants Spencer Stiles - Group President, Orthopedics and Spine Jason Beach - Vice...
3 Dividend-Growth Stocks That a Top-Rated Vanguard Fund Manager Likes
Add these names to your watchlist of dividend-growth stocks.
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately he...